Delivery Order SPE2DR25D3103-SPE2DR26F9P91
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,075.68 to AmerisourceBergen Drug Corp for 40,000 units/ml of Procrit (epoetin alfa), a pharmaceutical used to treat anemia. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by November 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,360.04 to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Procrit (epoetin alfa) 10,000 units/mL vials. This is a firm fixed-price delivery order with no set-aside designation, issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The product will be delivered to AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on December 16, 2025, by the Defense Logistics Agency for Procrit 20,000 units/ml vials with a ceiling value of $1,419.36. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order valued at $18,671.66 to AmerisourceBergen Drug Corp for 10,000 units/mL of Procrit, a pharmaceutical product used to treat anemia. The contract is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Procrit 40,000 units/ml vials, a pharmaceutical product used in treating anemia and related conditions. This firm fixed-price delivery order has a ceiling value of $4,092.76 and is scheduled for completion by August 8, 2025. The contract is not set-aside and represents a competitive award to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 10,000 units of Procrit (Epoetin alfa) 10,000 units/mL vials. The $2,273.25 firm-fixed-price contract has an ultimate completion date of August 16, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Procrit 10,000 units/ml vials valued at $5,089.52. This firm fixed-price delivery order is set to be completed by October 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside, competitively awarded contract, reflecting AmerisourceBergen's capability to meet federal pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,609.34 firm fixed-price delivery order is for the supply of 40,000 units/mL of the pharmaceutical product PROCRIT. The contract has an ultimate completion date of April 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
- The U.S. government agency Medical Supply Chain, which is part of the Defense Logistics Agency (DLA), awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a ceiling value of $1,307.36 and is for the delivery of 20,000 units/mL vials of PROCRIT, a medication used to treat anemia. The contract has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp is also the prime contractor on...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,288.54 firm fixed-price contract is for the delivery of 40,000 units/mL of the drug PROCRIT, with a completion date of March 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9P91Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,163.56 to AmerisourceBergen Drug Corp for 4,000 units/mL of Procrit (epoetin alfa), a pharmaceutical treatment used to address anemia in patients with chronic kidney disease and cancer. This competitively awarded, firm fixed-price delivery order was executed on December 16, 2025, with an ultimate completion date of December 17, 2025, and represents a child contract under AmerisourceBergen's larger federal contract portfolio. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive pharmaceutical supply vehicle providing a wide range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contract portfolio supplying critical medical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 12/15/25 |